Tuesday, 29 September 2026European Markets

NORDIC NANOVECTOR Stock Was 9.32% Up Today

Loading stream...

(VIANEWS) - The Market ended the session with NORDIC NANOVECTOR (NANOV.OL) rising 9.32% to kr0.80 on Thursday, following the last session's upward trend. Oslo Børs Benchmark Index_GI rose 0.63% to kr1,250.40, after three consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

NORDIC NANOVECTOR's last close was kr0.73, 95.37% below its 52-week high of kr15.78.

About NORDIC NANOVECTOR

Nordic Nanovector ASA, a biopharmaceutical company, develops and commercializes therapeutics for hematological cancers in Norway. The company's lead product candidate is Betalutin, a CD37-targeting antibody-radionuclide-conjugate, which is in Phase 2b clinical trial for the treatment of patients with non-hodgkin lymphoma. Its preclinical development product also includes Alpha37, an anti-CD37 alphaparticle emitting radioimmunoconjugate for treating chronic lymphatic leukemia. The company has collaboration agreements with Paul Scherrer Institute; ArevaMed; LegoChem Bio; and Heidelberg Pharma. It also has a research collaboration with the University of Pennsylvania to generate a CD37-targeting CAR-T cell approach as a treatment for patients with B-cell malignancies. The company was formerly known as Nordic Nanovector AS and changed its name to Nordic Nanovector ASA in 2014. Nordic Nanovector ASA was incorporated in 2009 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, NORDIC NANOVECTOR has a trailing twelve months EPS of kr-4.09.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -155.9%.

Volatility

NORDIC NANOVECTOR's last week, last month's, and last quarter's current intraday variation average was a negative 1.35%, a negative 1.18%, and a positive 3.53%.

NORDIC NANOVECTOR's highest amplitude of average volatility was 2.40% (last week), 2.61% (last month), and 3.53% (last quarter).

Yearly Top and Bottom Value

NORDIC NANOVECTOR's stock is valued at kr0.80 at 21:33 EST, way under its 52-week high of kr15.78 and way higher than its 52-week low of kr0.67.

Moving Average

NORDIC NANOVECTOR's value is way under its 50-day moving average of kr0.98 and way under its 200-day moving average of kr2.31.

Volume

Today's last reported volume for NORDIC NANOVECTOR is 466173 which is 73.69% below its average volume of 1772280.

More news about NORDIC NANOVECTOR (NANOV.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Vertical AI Agents Attract a Funding Wave Across Fintech-Adjacent Industries
A cluster of AI-native startups applying autonomous agents to narrow, operational problems — hotel front-desk staffing (Dextr AI), identity/fraud risk for financial institutions (Baselayer), insurance distribution (Napo, Connie Health, MGT Insurance) — closed seed-to-Series A rounds within days of each other in September 2026, with CB Insights running a coordinated CEO interview series to spotlight them. The pattern points to agentic AI maturing from generic chat tools into vertical, revenue-generating products, with identity verification for AI agents themselves (Baselayer) emerging as a new fintech infrastructure category responding directly to AI-driven fraud risk.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com